As of 2025-06-16, the EV/EBITDA ratio of Orchard Therapeutics PLC (ORTX) is -7.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ORTX's latest enterprise value is 761.19 mil USD. ORTX's TTM EBITDA according to its financial statements is -96.35 mil USD. Dividing these 2 quantities gives us the above ORTX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 14.6x | 13.7x |
| Forward P/E multiples | 27.2x - 34.5x | 34.0x |
| Fair Price | (57.70) - (30.99) | (50.60) |
| Upside | -445.5% - -285.6% | -403.0% |
| Date | EV/EBITDA |